Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qifu Huazhuo Formula is a Traditional Chinese Medicine (TCM) herbal composition developed by the Guangdong Provincial Hospital of Chinese Medicine for the treatment of metabolic and inflammatory conditions associated with gout. It is specifically investigated for its efficacy in patients with intercritical gout, chronic gouty arthritis, and hyperuricemia. The formula is designed to address the TCM patterns of "turbidity" and "kidney deficiency," which correspond to impaired uric acid excretion and chronic inflammation. Clinical evaluation includes comparing its efficacy and safety as a monotherapy against febuxostat, as well as assessing the synergistic effects of combining the two treatments to achieve target serum uric acid levels and reduce the frequency of acute gouty attacks.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qifu Huazhuo Formula.